Hagan Joseph P

Hagan Joseph P is listed in filings as Chief Executive Officer at Regulus Therapeutics Inc.. This profile follows SEC Form 4 activity through Jun 27, 2025, including sale activity and purchase activity. Recent filings connect the profile to Regulus Therapeutics Inc. (RGLS). The current snapshot covers public activity from Jan 10, 2025 to Jun 27, 2025. Reported amounts are shown as $297.5K to $14.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.